OBJECTIVE: We sought to determine the prevalence of any alcohol use and hazardous alcohol consumption among HIV-infected individuals engaged in care and to identify factors associated with hazardous alcohol use. METHODS: During 2003, 951 patients were interviewed at 14 HIV primary care sites in the USA. Hazardous drinking was defined as >14 drinks/week or >or=5 drinks/occasion for men and >7 drinks/week or >or=4 drinks/occasion for women. Moderate alcohol use was consumption at less than hazardous levels. We used logistic regression to identify factors associated with any alcohol use and hazardous alcohol use. RESULTS: Forty per cent of the sample reported any alcohol use in the 4 weeks prior to the interview; 11% reported hazardous use. In multivariate regression, male sex [adjusted odds ratio (AOR) 1.52 (95% confidence interval, CI, 1.07-2.16)], a college education (compared to<high school) [AOR 1.87 (1.10-3.18)] and illicit drug use [AOR 2.69 (1.82-3.95)] were associated positively with any alcohol use, while CD4 nadir >or=500 cells/microL [AOR 2.65 (1.23-5.69)] and illicit drug use [AOR 2.67 (1.48-4.82)] were associated with increased odds of hazardous alcohol use (compared to moderate and none). CONCLUSIONS: Alcohol use is prevalent among HIV-infected individuals and is associated with a variety of socioeconomic and demographic characteristics. Screening for alcohol use should be routine practice in HIV primary care settings.
OBJECTIVE: We sought to determine the prevalence of any alcohol use and hazardous alcohol consumption among HIV-infected individuals engaged in care and to identify factors associated with hazardous alcohol use. METHODS: During 2003, 951 patients were interviewed at 14 HIV primary care sites in the USA. Hazardous drinking was defined as >14 drinks/week or >or=5 drinks/occasion for men and >7 drinks/week or >or=4 drinks/occasion for women. Moderate alcohol use was consumption at less than hazardous levels. We used logistic regression to identify factors associated with any alcohol use and hazardous alcohol use. RESULTS: Forty per cent of the sample reported any alcohol use in the 4 weeks prior to the interview; 11% reported hazardous use. In multivariate regression, male sex [adjusted odds ratio (AOR) 1.52 (95% confidence interval, CI, 1.07-2.16)], a college education (compared to<high school) [AOR 1.87 (1.10-3.18)] and illicit drug use [AOR 2.69 (1.82-3.95)] were associated positively with any alcohol use, while CD4 nadir >or=500 cells/microL [AOR 2.65 (1.23-5.69)] and illicit drug use [AOR 2.67 (1.48-4.82)] were associated with increased odds of hazardous alcohol use (compared to moderate and none). CONCLUSIONS:Alcohol use is prevalent among HIV-infected individuals and is associated with a variety of socioeconomic and demographic characteristics. Screening for alcohol use should be routine practice in HIV primary care settings.
Authors: John A Fleishman; Kelly A Gebo; Erin D Reilly; Richard Conviser; W Christopher Mathews; P Todd Korthuis; James Hellinger; Richard Rutstein; Philip Keiser; Haya Rubin; Richard D Moore Journal: Med Care Date: 2005-09 Impact factor: 2.983
Authors: Frank H Galvan; Eric G Bing; John A Fleishman; Andrew S London; Raul Caetano; M Audrey Burnam; Doug Longshore; Sally C Morton; Maria Orlando; Martin Shapiro Journal: J Stud Alcohol Date: 2002-03
Authors: E Rosenthal; G Pialoux; N Bernard; C Pradier; D Rey; M Bentata; C Michelet; S Pol; C Perronne; P Cacoub Journal: J Viral Hepat Date: 2007-03 Impact factor: 3.728
Authors: Anne-Déborah Bouhnik; Marie Préau; France Lert; Patrick Peretti-Watel; Marie-Ange Schiltz; Yolande Obadia; Bruno Spire Journal: AIDS Date: 2007-01 Impact factor: 4.177
Authors: Robyn C Neblett; Heidi E Hutton; Bryan Lau; Mary E McCaul; Richard D Moore; Geetanjali Chander Journal: J Womens Health (Larchmt) Date: 2011-01-31 Impact factor: 2.681
Authors: Derrick R Samuelson; Robert W Siggins; Sanbao Ruan; Angela M Amedee; Jiusong Sun; Quan Karen Zhu; Wayne A Marasco; Christopher M Taylor; Meng Luo; David A Welsh; Judd E Shellito Journal: Alcohol Date: 2018-09-11 Impact factor: 2.405
Authors: Anne K Monroe; Bryan Lau; Michael J Mugavero; William C Mathews; Kenneth H Mayer; Sonia Napravnik; Heidi E Hutton; Hongseok S Kim; Sarah Jabour; Richard D Moore; Mary E McCaul; Katerina A Christopoulos; Heidi C Crane; Geetanjali Chander Journal: J Acquir Immune Defic Syndr Date: 2016-12-01 Impact factor: 3.731
Authors: Linda M Skalski; Melissa H Watt; Jessica C MacFarlane; Rae Jean Proeschold-Bell; Jason E Stout; Kathleen J Sikkema Journal: N C Med J Date: 2015 Jul-Aug
Authors: Michael J Silverberg; Tory Levine-Hall; Nicole Hood; Alexandra N Anderson; Stacey E Alexeeff; Jennifer O Lam; Sally B Slome; Jason A Flamm; Charles Bradley Hare; Thekla Ross; Amy C Justice; Jonathan A C Sterne; Andrew E Williams; Kendall J Bryant; Constance M Weisner; Michael A Horberg; Stacy A Sterling; Derek D Satre Journal: Alcohol Clin Exp Res Date: 2020-11-10 Impact factor: 3.455
Authors: Philip T Korthuis; Paula J Lum; Pamela Vergara-Rodriguez; Keith Ahamad; Evan Wood; Lynn E Kunkel; Neal L Oden; Robert Lindblad; James L Sorensen; Virgilio Arenas; Doan Ha; Raul N Mandler; Dennis McCarty Journal: Addiction Date: 2017-02-08 Impact factor: 6.526
Authors: Anthony T Fojo; Catherine R Lesko; Keri L Calkins; Richard D Moore; Mary E McCaul; Heidi E Hutton; William C Mathews; Heidi Crane; Katerina Christopoulos; Karen Cropsey; Michael J Mugavero; Kenneth Mayer; Brian W Pence; Bryan Lau; Geetanjali Chander Journal: AIDS Behav Date: 2019-03
Authors: J Danielle Sharpe; Zhi Zhou; César G Escobar-Viera; Jamie P Morano; Robert J Lucero; Gladys E Ibañez; Mark Hart; Christa L Cook; Robert L Cook Journal: Subst Abus Date: 2017-09-01 Impact factor: 3.716